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ABSTRACT
Tuberculosis disease (TB), caused by Mycobacterium tuberculosis, is a major public health issue in Thailand. The high
prevalence of modern Beijing (Lineage 2.2.1) strains has been associated with multi- and extensively drug-resistant
infections (MDR-, XDR-TB), complicating disease control. The impact of rarer proto-Beijing (L2.1) strains is less clear. In
our study of thirty-seven L2.1 clinical isolates spanning thirteen years, we found a high prevalence of XDR-TB cases
(32.4%). With≤ 12 pairwise SNP distances, 43.2% of L2.1 patients belong to MDR-TB or XDR-TB transmission clusters
suggesting a high level of clonal expansion across four Thai provinces. All XDR-TB (100%) were likely due to
transmission rather than inadequate treatment. We found a 47 mutation signature and a partial deletion of the
fadD14 gene in the circulating XDR-TB cluster, which can be used for surveillance of this rare and resilient
M. tuberculosis strain-type that is causing increasing health burden. We also detected three novel deletion positions,
a deletion of 1285 bp within desA3 (Rv3230c), large deletions in the plcB, plcA, and ppe38 gene which may play a role
in the virulence, pathogenesis or evolution of the L2.1 strain-type.
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Introduction
Tuberculosis (TB), caused by Mycobacterium tuber-
culosis, is one of the top 10 causes of mortality glob-
ally. The global problem of drug-resistant TB,
especially multi (MDR-TB) and extensive (XDR-
TB) forms, is complicating disease control [1]. TB
in Thailand remains high with an estimated 153
per 100,000 populations while around 50,167 cases
were bacteriologically confirmed in 2018. An esti-
mated 4000 MDR/RR-TB, including 1312 confirmed,
were among notified pulmonary TB cases [1]. Treat-
ment for patients with drug-resistant TB is pro-
longed, expensive and outcomes are poor. Drug
resistance in M. tuberculosis is almost exclusively
due to mutations including single nucleotide poly-
morphisms (SNPs) in genes coding for drug-targets
or -converting enzymes [2,3]. Whole-genome
sequencing (WGS) platforms are being used to
understand the mutations underlying drug resistance
and to characterize transmission, where
M. tuberculosis isolates (sourced from different
hosts) that have near-identical genomic variation
are most likely to have arisen from a recent trans-
mission event [4]. Using WGS, molecular epidemio-
logical studies can investigate the cause of emerging
drug resistance and focus on the contribution of
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potential genetic and environmental risk factors
across a population to plan for TB control.
The M. tuberculosis complex has 8 main lineages
(L1-8) [5], which vary in their geographic distribution
and spread, with L1 (Indo-Oceanic) and L2 (East
Asian) the predominant ones circulating in Thailand
[6–10]. The modern Beijing sublineage (L2.2.1;
AAF3) has been continuously reported to be associ-
ated with clonal expansion of MDR-TB [6,7,11]. In
contrast, the “Manu-ancestor” or “proto-Beijing” gen-
otype (spoligotype 523, lineage 2.1; [9]) has a lower
prevalence [6,10], with few reports, including detec-
tion in the Chiba prefecture in Japan [12] and Guangxi
province of Southern China [13]. Recently, we noticed
a potential transmission event involving proto-Beijing
strains causing XDR-TB [7]. To understand if there is
further transmission of the L2.1 strain and any related
XDR-TB clonal expansion, we have analysed the WGS
from thirty-seven isolates collected over 13-year
period from 14 provinces of Thailand.
Methods
L2.1 samples and sequencing
Clinical isolates sourced from 725 TB patients across
42 of 77 provinces from Thailand were classified as
MDR-TB, pre-XDR, XDR-TB and pan-susceptible by
applying phenotypic drug susceptibility testing
(DST) assays using drug-containing MiddleBrook
7H10 agar (M7H10). The 723 culturable isolates
were from the retrievable stock cultures of 1415
MDR-, pre-XDR and XDR-TB from the Drug-Resist-
ant Tuberculosis Research Fund Laboratory. These
isolates were obtained from pulmonary TB patients
diagnosed between 2005 and 2012 and covering 42
of 76 provinces in Thailand. All isolates were sub-cul-
tured on Loewenstein-Jensen media and incubated at
37°C for four weeks. Multiple loopfulls of
M. tuberculosis colonies were taken and DNA extrac-
tion was carried out using the cetyltrimethylammo-
nium bromide-sodium chloride method [14].
Genomic DNAs were sequenced using Illumina plat-
forms, across a number of sites, including Novogene
AIT (Singapore), Genomic Institute Singapore (GIS),
London School of Hygiene & Tropical Medicine,
and Mahidol University. We applied the TBProfiler
tool [15] to the WGS data to in-silico strain-type,
and identified 35 (4.8%) isolates as L2.1 strains. To
determine the genetic similarity between currently
and recently circulating L2.1 causing XDR-TB, two
recent L2.1 XDR-TB isolates (2015 and 2017) from
Kanchanaburi province were blended into this study.
Here L2.1 collection (n = 37) represents the largest
number of L2.1 strains from Thailand. The raw
sequencing data for the 37 samples are deposited in
NCBI’s Sequence Read Archive (SRA) database
(BioProject ID PRJNA63078). They were analysed
together with other 19 L2.1 M. tuberculosis strains
obtained from public data; 16 isolates from high
prevalence area (China), one isolate from the neigh-
bouring country (Laos), and two well-characterized
L2.1 isolates from the Sanger Institute [16–19]. The
accession numbers of all 56 genomes are listed in
Table S1. The 37 L2.1 M. tuberculosis were isolated
from Thai-patients, across 19 districts among 14 pro-
vinces, between 2005 and 2017 by the Drug-Resistant
Tuberculosis Research Fund, Faculty of Medicine Sir-
iraj Hospital, Mahidol University, Bangkok (patient
no.1–19 and 22–37) and the National Reference
Tuberculosis Laboratory (patient no. 20 and 21). Epi-
demiological linkage between patients was not
documented.
Ethics statement
Approval for the study was given by the Ethical and
Scientific Committees of the Faculty of Medicine Sir-
iraj Hospital, Mahidol University (EC No. 510/2561)
and the Center for Ethics in Human Research, Khon
Kaen University (HE601249).
Bioinformatics analysis
The L2.1 isolates (n = 56) consisted of 37 strains from
our collection and 19 globally distributed. The quality
of their sequence reads was checked using FastQC
(v0.11.7) [20,21]. Sequencing reads were mapped to
the M. tuberculosis H37Rv reference genome
(NC_000962.3) using BWA-MEM software [22]. The
sets of mapped paired-end reads were joined using
the SAMtools suite. Variants were called using
GATK software (v3.8) with HaplotypeCaller in -ERC
GVCF mode for generating gVCF files. Multiple
gVCF files were aggregated and combined into one
GVCF file using GATK GenotypeGVCFs. Only the
single nucleotide polymorphisms (SNPs) from VCF
output were extracted using SelectVariants tool and
filtered using VariantFiltration [23]. The snpEff soft-
ware (v4.2) was used for variant annotation [24].
SNPs determined in the repetitive regions, paralogous
gene families, and drug-resistant genes were discarded
using VCFtools [25]. SNPs with allelic frequencies less
than 75% or read-depth less than 10 reads were
removed. The resulting set of high-confidence SNPs
were used to construct a phylogenetic tree based on
the maximum likelihood method and 1000 bootstrap
replicates using RAxML (v8.0.0) software [26]. iTOL
software was used for visualizing the phylogenetic
trees [27]. Drug-resistance profiles (and lineages)
were predicted in-silico using TBProfiler (v2.0) [15].
Spoligotypes were predicted using SpoTyping [28].
The in-silico analysis for 31 known regions of differ-
ences (RDs) was performed by RD-Analyzer [18].
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DELLY software [29] was used to predict large struc-
tural variants (SVs) using minimum paired-end map-
ping quality 20 and standard deviation units as 3
times. High-quality SVs had to be supported by
paired-end and split reads. All variants across the
samples were merged into a single file using BCFtools
software. All putative genetic markers were manually
reviewed for accuracy using Integrated Genomic
Viewer software [30], and, if considered as true variant
they were included for delineation.
Results
Setting and expansion of M. tuberculosis L2.1
in Thailand
The 37 clinical M. tuberculosis strains used were iso-
lated from pulmonary TB patients in 14 provinces
from 2005 to 2017. In 2005, the L2.1 sub-lineage was
found only in Kanchanaburi and Bangkok. Seven
years later, L2.1 were found across 14 provinces and
5 were XDR-TB (Figure 1).
The overall rate of MDR-TB individuals with pre-
XDR and XDR-TB are high. Twelve isolates (32.4%)
are XDR-TB whereas 7 isolates (18.9%) are pre-
XDR. Sixteen isolates are MDR-TB (43.2%) and the
remaining 2 isolates are pan-susceptible. Demo-
graphic data of each patient is shown in (Table 1
and Table S1). The L2.1 incident rate (n = 37 or
5.1%) was high compared with studies in the Chian-
grai province, Northern Thailand (1.0%) [10] and
Guangxi province of Southern China (0.2%) [13].
Unfortunately, our collection had no isolates from
Chiangrai. Within province the highest number of
L2.1 strain was observed in Kanchanaburi (n = 13),
followed by Nakhon Ratchasima (n = 5), Buriram
and Bangkok (n = 3) province.
Genotyping analysis of the rare genotype L2.1
isolates in Thailand
The genotypic drug-resistance profile of each isolate is
shown in Figure 2. In silico spoligotyping classified the
37 L2.1 strains into 12 genotypes, and the most com-
mon spoligotype (23/37; 62.2%) was SIT 523
(777777777777771). Of these SIT 523 isolates, 12
(52.2%) were XDR-TB, and were sourced from 4 pro-
vinces; Chachoengsao (n = 1), Kanchanaburi (n = 9),
Ratchaburi (n = 1), Suphanburi (n = 1) (Figures 1
and 2). All isolates harboured the extended RD105
deletion but had RD207, RD181 and pks15/1 regions
intact.
To investigate the within and between country
spread of L2.1, an analysis of the genome variation
of all 56 isolates (Thailand, China, Laos, and others)
was performed. A total of 3685 high-confidence
SNPs were identified across 56M. tuberculosis isolates,
including 3206 (87.0%) in coding regions (1141 silent,
2028 missense, and 37 nonsense), 12 in non-coding
and 467 in intergenic regions (Table S2). Across the
56 isolates, 2484 (67.4%) SNPs were identified in
single isolates. A phylogenetic tree based on the 3685
SNPs identified revealed that Thai-isolates were
mostly interleaved with other countries including
China (CHA), Laos (LAO), and others (NA) (Figure
2). All 12 (100%) XDR-TB isolates were clustered
together and were distinguished from the others by
at least 47 SNPs. Twenty-seven of 47 SNPs had mis-
sense mutations. This large and long-lasting mono-
phyletic clade with high bootstrap support (100%)
included XDR-TB cases from Kanchanaburi (n = 9).
The clade was also interleaved with XDR-TB isolates
from Ratchaburi (n = 1), Chachoengsao (n = 1), and
Supanburi (n = 1) (Figure 3(A)). The time range
between the first and last isolate was 13 years (2005–
2017). Moreover, the results revealed that 2 (28.6%)
pre-XDR and 2 (12.5%) MDR-TB patients identified
were limited to one geographic district and separated
by at least 90 SNPs and 60 SNPs, respectively, from
any other study isolates. This result implies that this
particular strain was circulating locally. A genotypic
clustering rate of 43.2% was found among patients
who were infected with L2.1 strain, revealing the
high level of transmission in this population.
Evidence of transmission
Potential transmission clusters were revealed by deter-
mining the pairwise SNP distance between the 37
Thai-isolates. The pairwise genetic distance varied
between 0 and 381 SNPs (Table S3). Using a 12 SNP
cut-off [31], 43.2% of patients belonged to 3 different
possible clusters, including: (i) an XDR-TB cluster
with a maximum size of 12 isolates (Figure 3(B)),
(ii) 2 pre-XDR isolates, and (iii) 2 MDR-TB isolates.
Mutation patterns associated with resistance were
also unique for each cluster (Table S4), providing
potential evidence of transmission. The MDR-TB
cluster (n = 2; no.14 (2008) and 16 (2009)) was com-
posed of patients from the same district and had iden-
tical SNP patterns, including mutations known to be
responsible for drug resistance (rpoB Ser450Leu;
katG Ser315Thr). Within the pre-XDR cluster (n =
2; no.4 (2008) and 6 (2012)), there was only 1 SNP
difference (a synonymous mutation difference
between isolates 4 and 6), and the established drug-
resistance mutations were identical (katG Ser315Thr;
rpoB Ser450Leu; rpsL Lys88Arg; embB Gly406Asp;
pncA Tyr103His; gyrA: Asp94Asn; thyA deletion
3071595-3077080). For the XDR-TB cluster (n = 12),
the pairwise genetic distance varied between 1 and
11 SNPs. Nine (75.0%) XDR-TB were isolated from
Kanchanaburi province, including Thamaka (n = 5;
no.9 (2005), 12 (2007), 15 (2008), 20 (2015), and 21
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Figure 1. Geographic distribution of pan-susceptible (green), MDR-TB (yellow), pre-XDR (pink), and XDR-TB (dark red) caused by
M. tuberculosis L2.1. Each province has been shaded according to the frequency of sample collection including Bangkok (BAN),
Buriram (BUR), Chachoengsao (CHA), Chonburi (CHO), Kanchanaburi (KAN), Nakhonratchasima (NAK), Nongkhai (NON), Phetcha-
bun (PHE), Phrae (PHR), Ratchaburi (RAT), Rayong (RAY), Saraburi (SAR), Suphanburi (SUP), and Suratthani (SUR).
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(2017)), Muang (n = 2; no.11 (2007) and 13 (2008)),
Bophloi (n = 1; no.10 (2006)) and Thamuang (n = 1;
no.19 (2012)) districts. The other three isolates col-
lected from patient in Chachoengsao (no.7 in 2008),
Rachaburi (no.31 in 2012), and Suphaburi (no.35 in
2011). Ten (83.3%) XDR isolates had identical resist-
ance mutation profiles (katG Ser315Thr; rpoB Ser450-
Leu; embB Met306Ile; pncA Ile90Ser; rrs: 1401a > g;
gyrA Asp94Gly; folC Glu40Gly). XDR-TB samples
from Chachoengsao (no.7), and Suphanburi (no.35)
were located 174 and 64.7 kilometres, respectively,
away from earlier isolates. They had identical drug-
resistant mutations to the majority of the XDR-TB
cluster, except for the addition of the Leu527Val
mutation in the (rifampicin compensatory) rpoC
gene. The recent isolate (no. 20; year 2015) had an
additional mutation (thyX −16C > T) related to para-
aminosalicylic acid resistance. These results suggest
that there was a long-term transmission of local clus-
ters of XDR-TB, which carried common drug-resist-
ance mutations, thereby explaining its success as a
spreader [32–34].
During the study period, the first XDR-TB case
(patient no. 9) was infected with an L2.1 XDR-TB
clone from Kanchanaburi in 2005. Subsequent events
have revealed that the XDR-TB clone has emerged
continuously, of which 12 had at least one isolate
over a span of 13 years, and been restricted to within
180 km across four provinces from the first case.
Structural diversity in clonal cluster population
Structure variations (SVs) were called relative to the
M. tuberculosis H37Rv reference genome. Thirty-
nine high-quality SVs were detected. Three common
deletion regions across all combined dataset of L2.1
isolates were detected with sizes between 827 and
4824 bp (Table 1), all exclusive to the sub-lineage.
The largest genome SV involved a deletion of plcA
(Rv2351c) and PPE38 (Rv2352c), and a partial del-
etion of plcB (Rv2350c). There were deletions unique
to the clusters (MDR-TB 2; pre-XDR 2). Twelve iso-
lates belonging to the XDR-TB cluster contained one
unique deletion in the Rv1058 region, which was not
found in any other isolates.
Discussion
The recent emergence of drug-resistant TB infections
in Thailand has been attributed to strains in
M. tuberculosis lineage 2, particularly the “modern
Beijing” (Lineage 2.2.1) sub-lineage. M. tuberculosis
from this sub-lineage are highly virulent causing dis-
ease outbreaks, with escape from the effects of BCG
vaccination, they disseminate efficiently, and easily
acquire antibiotic resistance [6,7,9,35]. The more
rare “proto-Beijing” (L2.1) appears to be transmitting,
and has a high propensity to be XDR-TB. In our study,
the number of MDR-TB individuals with XDR-TB is
∼6 times greater than the WHO global estimate
(6.2%) [1], and all are clustered. Poor treatment adher-
ence is not the only factor that contributes to drug
resistance, but also the failure in controlling trans-
mission of drug-resistant strains.
This study was a hospital-based retrospective analy-
sis included the retrospective and passive nature of
case-finding, based only on retrievable isolates from
stock cultures during 2005–2012; therefore, they
were a set of convenience isolates and may not be
representative of all isolates from the community,
and we cannot exclude some unintended bias.
Additionally, TB database information of Thailand
during 2005–2012 was not well developed, and the
capacity of the laboratory to perform phenotypic
Table 1. SVs identified among the L2.1 sub-population. The position is relative to the M. tuberculosis H37Rv reference genome
(NC_000962.3).
Uniqueness SV types Start Stop Genes Gene symbols and descriptions
MDR-TB cluster Deletion 2900282 2900432 Rv2576c membrane protein
Deletion 2900903 2901086 Rv2577 hypothetical protein_metallophosphatase superfamily




Deletion 2851350 2851718 Rv2527 vapC17: ribonuclease

















PPE43: PPE family protein PPE43
pe27: PE family protein PE27
XDR-TB cluster Deletion 1180695 1180773 Rv1058 fadD14: fatty-acid–CoA ligase
All isolates Deletion 2010609 2011436 Rv1777 cyp144: cytochrome P450
Deletion 3606557 3607841 Rv3229c
Rv3230c
desA3: stearoyl-CoA 9-desaturase
stearoyl-CoA 9-desaturase electron transfer protein
Deletion 2629526 2634350 Rv2350c
Rv2351c
Rv2352c
plcB: membrane-associated phospholipase B
plcA: membrane-associated phospholipase A
PPE38: PPE family protein PPE38
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Figure 2. Genetic diversity and distribution of 56 M. tuberculosis L2.1 strains. Phylogenetic tree based on maximum likelihood
method using 3685 high-confidence SNPs with their collection site, spoligotyping pattern drug-resistance phenotype, drug-resist-
ance mutation, and year of collection (from inner to the outer circles). The red branch indicated the potential transmission clusters.
Figure 3. (A) Map of Thailand annotated with the collection site of MDR- (dark green), pre-XDR (pink), and XDR-TB (dark red)
cluster; (B) Frequency of pairwise genetic distance among 37 samples from Thai-patients; pan-susceptible (light blue), MDR-TB
(dark green), pre-XDR (pink), and XDR-TB (dark red).
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drug susceptibility testing was also limited. However,
the number of L2.1 isolates retrieved is the largest to
date from a single country, and the underlying
sampling from 725 culturable M. tuberculosis covers
42 of 77 provinces [2,6,7,17]. Here we reported the
presence of L2.1 isolates, including in Bangkok,
Buriram, Chachoengsao, Chonburi, Kanchanaburi,
Nakhonratchasima, Nongkhai, Phetchabun, Phrae,
Ratchaburi, Rayong, Saraburi, Suphanburi, and Surat-
thani, but not Chiangrai provinces [7,10].
WGS data were integrated with routinely clinical
information to identify the putative TB cluster.
Unfortunately, epidemiological information was not
available in this study. The integration of social-net-
work analysis with high-resolution bacterial genome
sequencing would provide traceable information in
evaluating TB transmission [36]. The 12-SNP dis-
tance was proposed by using studies in low incidence
TB settings [31], and seems reasonable for our study,
set in the contexts of low L2.1 population prevalence
and the community transmission investigation.
Using clustering threshold of 12 SNPs, we defined 3
distinct unique clonal clusters which carried particu-
lar drug-resistant mutation pattern for each clone
(Table S4), implying diverse evolution histories for
the individual population. A high clustering rate of
43.2% among L2.1 infected patients highlighted the
high transmissibility of proto-Beijing strains. Two
of the three clusters identified had one pair of strains
and emerged in a particular region. Among the lar-
gest possible cluster groupings consisting of twelve
XDR-TB transmission clusters, at least seven putative
transmission events were postulated to underlie the
largest cluster on the basis of a shared social setting
and WGS genotyping, in which each individual iso-
late was supposed to be accumulated genetic diversity
within-host [31]. Nine isolates were retrieved from
patients in Kanchanaburi province, of which four
district hospitals were involved in four putative
transmission events; 5 (41.7%) isolates from Tha-
maka, 2 isolates from Muang, 1 isolate from Tha
muang, and 1 isolate from Bo phloi district. The
other 3 events were possibly infected through social
contact in Chachoengsao (patient no.7), Rachaburi
(patient no.31), and Supanburi (patient no.35). How-
ever, the potential of clonal expansion reported here
would switch attention towards a rare genotype caus-
ing XDR-TB in Kanchanaburi province, not only in a
particular hospital but through the high prevalence of
MDR-TB, especially within L2.2.1; AAF3
[7,11,36,37]. The lack of transfer of these hyper-
resistant strains to other geographical locations may
be associated with adaptation to local-host popu-
lation, as seen in L1 strains [9] or other factors
which need to be explored in the future.
Forty-seven SNPs and a 78 bp deletion in fadD14
(encoded fatty-acid–CoA ligase) were present in all
XDR-TB clonal spreaders, but not other isolates
studied. Notably, 27 (of the 47) SNPs resulted in a mis-
sense mutation and were potentially subject to natural
selection. The genetic markers shared by the successful
XDR-TB cluster could be related to virulence or used
to screen for the existence of antibiotic-resistant bac-
teria. Specific resistance-conferring mutations and
strain genetic background are often associated with a
fitness cost [32,33]. The local clusters of XDR-TB car-
ried common drug-resistance mutations, potentially
explaining its successful spreading phenotype more
readily than other genotypes. Unavoidably, host gen-
etic background also influences the response to myco-
bacterial activity [6,17]. The successive appearance of
XDR-TB cluster conferred overgrowth their ancestral
drug-susceptible clone that become undetectable in
this study. Mutations found within the XDR-TB clus-
ter indicate a remarkable adaptation capacity during
infection. Further, the factors influencing
Figure 3 Continued
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transmission remain poorly understood, but as WGS
becomes routine in a clinical setting, it will be possible
to reconstruct the transmission chains and assess the
host and M. tuberculosis genetic and non-genetic fac-
tors affecting transmissibility.
We detected three novel deletion positions which
may play a role in the virulence, pathogenesis or evol-
ution of the L2.1 strain-type. Poorer bacterial growth
has been observed in presence of azole in
M. tuberculosis strains with CYP144 knockout [38].
Azole drugs may have activity against the L2.1 strain.
Further, a deletion of 1285 bp within desA3 and oxido-
reductase Rv3230c may cause the L2.1 strain to be
resistant to the second-line anti-TB drug isoxyl [39].
Large deletions in the plcB, plcA, and ppe38 gene
were also detected. The deletion of ppe38 and loss of
ESX-5 substrates secretion as found in modern Beijing
sub-lineages may have increased their virulence and
contributed to their global spread [40]. Whereas par-
tial deletion of phospholipase C encoded by plc
genes (plcA, B, C and D) may have a role in assisting
the bacteria to escape from phagosomal containment,
as found in Listeria monocytogenes or Clostridium per-
fringens [41]. This may cause lower virulence than a
modern Beijing sub-lineage.
Overall, our study has revealed that M. tuberculosis
sub-lineage L2.1 is geographically restricted but has a
great propensity to be XDR-TB and transmit. We
anticipate that revealing the XDR-TB burden of sub-
lineage L2.1 will lead to more widespread surveillance
and much-needed epidemiological studies. The strong
recommendation from the Thailand national TB con-
trol program to implement N95 or equivalent mask
wearing for active TB patients especially MDR-, pre-
XDR and XDR-TB patients will be an additional
measure to prevent TB transmission during intensive
treatment.
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